<DOC>
	<DOCNO>NCT01545635</DOCNO>
	<brief_summary>Severe traumatize patient ( ISS &gt; 15 ) admit emergency department ( ED ) University Hospital Innsbruck obvious bleed and/or risk significant hemorrhage screen rotational thrombelastometry ( ROTEM ) assay ED treatment subsequent surgical/radiological intervention coagulopathy ( T0 ) . If patient meet inclusion criterion ( T1 ) recruit study , first study related blood sample ( 40mL ) drawn , data collect . Subsequently , 100 patient randomized receive Fibrinogen concentrate and/or Prothrombin complex concentrate and/or FXIII concentrate reversal coagulopathy , 100 patient receive fresh frozen plasma ( FFP ) , respectively . Treatment failure register bleeding persists ROTEM parameter improve two time dosage study drug . In case haemostatic rescue therapy administer . CFC ( fibrinogen concentrate and/or PCC , and/or FXIII concentrate ) administer patient randomized receive FFP FFP administer patient CFC group . In case unresponsive comprehensive treatment normal ROTEM combine diffuse bleeding , haemostatic medication administer ( e.g rFVIIa , DDAVP , VWF/FVIII concentrate ) judge anesthetist charge . The need type rescue therapy document ROTEM perform thereafter . At admission ICU ( T0 ICU ) , 24h ( T24 ICU ) 48h ( T48 ICU ) thereafter study related blood sample draw ( 40mL ) . The indication transfusion red blood cell platelet , administration antifibrinolytics , treatment acidosis , hypothermia , hypocalcemia volume replacement similar group treatment perform accord clinical routine . Besides coagulation management ED treatment 24h ICU , patient 's care influence study follow clinical routine .</brief_summary>
	<brief_title>RETIC Trial : Reversal Trauma Induced Coagulopathy Using Coagulation Factor Concentrates Fresh Frozen Plasma</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>1 . Male female subject =/ &gt; 18 year =/ &lt; 80 year 2 . Major trauma ( ISS &gt; 15 ) 3 . Clinical sign ongoing bleed patient risk significant haemorrhage assess judged ED team charge patient 4 . Presence coagulopathy define ROTEM assay follow , Patients concomitant decrease fibrinogen polymerisation ( ROTEM® FibTEM A10 &lt; 7 mm 10 min ) Patients concomitant decreased coagulation factor level ( ROTEM® ExTEM CT &gt; 90 sec ) 1 . Lethal injury 2 . CPR scene , 3 . Isolated brain injury , burn injury 4 . Avalanche injury 5 . Administration FFP coagulation factor concentrate ED admission 6 . Delayed ( &gt; 6hours trauma ) admittance ED 7 . Known use oral anticoagulant , platelet aggregation inhibitor within 5 day injury 8 . Known history severe allergic reaction plasma product 9 . Known history congenital hemostasis disturbance , IgA Protein C deficiency 10 . Patients history thromboembolic event heparin induce thrombocytopenia ( HIT ) type 2 within last year 11 . Patients body weight &lt; 45kg &gt; 150kg 12 . Patients know pregnant 13 . Jehova 's Witness 14 . Known participation another clinical trial 15 . Patient know refusal participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Major trauma</keyword>
	<keyword>Injury Severity Score</keyword>
	<keyword>ISS &gt; 15</keyword>
	<keyword>clinical sign</keyword>
	<keyword>risk blood loss</keyword>
	<keyword>coagulopathy</keyword>
	<keyword>rotational thrombelastometry</keyword>
	<keyword>ROTEM</keyword>
</DOC>